Skip to main content

Animations

MJFF Publications

5871 - 5880 of 8471 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181471
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation
    Journal Name: Glia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/glia.23482
    Citation Count: 50
  • Summary Details
    OPEN
    Title: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2018.00326
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1337-8
    Citation Count: 42
  • Summary Details
    OPEN
    Title: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-34490-9
    Citation Count: 139
  • Summary Details
    OPEN
    Title: A comprehensive screening of copy number variability in dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27523
    Best OA location URL:
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012
    Citation Count: 275
  • Summary Details
    OPEN
    Title: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddy365
    Citation Count: 64
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.